Assessment of multidrug resistance, clonality and virulence in non-PCV-13 Streptococcus pneumoniae serotypes in Canada, 2011-13

Journal of Antimicrobial Chemotherapy

Volumn 70, Issue 7, 2015, Pages 1960-1964

  Golden, Alyssa R ^a   Adam, Heather J ^a,b   Gilmour, Matthew W ^a,c   Baxter, Melanie R ^a   Martin, Irene ^c   Nichol, Kimberly A ^b   Demczuk, Walter H B ^c   Hoban, Daryl J ^a,b   Zhanel, George G ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

^b HEALTH SCIENCES CENTRE   (Canada)

^c PUBLIC HEALTH AGENCY OF CANADA   (Canada)

Author keywords

Antimicrobial drug resistance; MLST; Multilocus sequence typing; Non PCV 13 serotypes; S. pneumoniae

Indexed keywords

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL VIRULENCE; BACTERIUM ISOLATION; CANADA; CLONAL VARIATION; CLONE; MULTIDRUG RESISTANCE; MULTILOCUS SEQUENCE TYPING; NONHUMAN; SEROTYPE; STREPTOCOCCUS PNEUMONIAE; UNITED STATES;

EID: 84936945392     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkv061     Document Type: Article

References (20)

1. CDC. Direct and indirect effects of routine vaccination of children with 7-valent pneumococcal conjugate vaccine on incidence of invasive pneumococcal disease-United States, 1998-2003. MMWR Morb Mortal Wkly Rep 2005; 54: 893-7.
2. Pilishvili T, Lexau C, Farley MM et al. Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine. J Infect Dis 2010; 201: 32-41.
3. National Advisory Committee on Immunization (NACI). Update on the use of conjugate vaccines in childhood. Can Commun Dis Rep 2010; 36: 1-21.
4. Adam HJ, Karlowsky JA, Nichol KA et al. Baseline epidemiology of Streptococcus pneumoniae serotypes in Canada prior to the introduction of the 13-valent pneumococcal vaccine. Microb Drug Resist 2012; 18: 176-82.
5. Demczuk WH, Martin I, Griffith A et al. Serotype distribution of invasive Streptococcus pneumoniae in Canada during the introduction of the 13-valent pneumococcal conjugate vaccine, 2010. Can J Microbiol 2012; 58: 1008-17.
6. Richter SS, Heilmann KP, Dohrn CL et al. Changing epidemiology of antimicrobial-resistant Streptococcus pneumoniae in the United States, 2004-2005. Clin Infect Dis 2009; 48: e23-33.
7. Gertz RE Jr, Li Z, Pimenta FC et al. Increased penicillin nonsusceptibility of nonvaccine-serotype invasive pneumococci other than serotypes 19A and 6A in post-7-valent conjugate vaccine era. J Infect Dis 2010; 201: 770-5.
8. Barocchi MA, Ries J, Zogaj X et al. A pneumococcal pilus influences virulence and host inflammatory responses. Proc Natl Acad Sci USA 2006; 103: 2857-62.
9. Regev-Yochay G, Hanage WP, Trzcinski K et al. Re-emergence of the type. 1. pilus among Streptococcus pneumoniae isolates in Massachusetts, USA. Vaccine 2010; 28: 4842-6.
10. Austrian R. The Quellung reaction, a neglected microbiologic technique. Mt Sinai J Med 1976; 43: 699-709.
11. Clinical and Laboratory Standards Institute. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically-Ninth Edition: Approved Standard M7-A9. CLSI, Wayne, PA, USA, 2012.
12. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing: Twenty-fourth Informational Supplement M100-S24. CLSI, Wayne, PA, USA, 2014.
13. Zahner D, Gudlavalleti A, Stephens DS. Increase in pilus islet 2-encoded pili among Streptococcus pneumoniae isolates, Atlanta, Georgia, USA. Emerg Infect Dis 2010; 16: 955-62.
14. McEllistrem MC, Stout JE, Harrison LH. Simplified protocol for pulsedfield gel electrophoresis analysis of Streptococcus pneumoniae. J Clin Microbiol 2000; 38: 351-3.
15. Louie M, Louie L, Papia G et al. Molecular analysis of the genetic variation among penicillin-susceptible and penicillin-resistant Streptococcus pneumoniae serotypes in Canada. J Infect Dis 1999; 179: 892-900.
16. Strachan JE, Rowe SL, Dunne EM et al. Emergence of Streptococcus pneumoniae serotype 15A after the introduction of the conjugate vaccine in Victoria. Med J Aust 2013; 199: 461-3.
17. Sa-Leao R, Tomasz A, Sanches IS et al. Carriage of internationally spread clones of Streptococcus pneumoniae with unusual drug resistance patterns in children attending day care centers in Lisbon, Portugal. J Infect Dis 2000; 182: 1153-60.
18. Pichon B, Ladhani SN, Slack MP et al. Changes inmolecular epidemiology of Streptococcus pneumoniae causing meningitis following introduction of pneumococcal conjugate vaccination in England and Wales. J Clin Microbiol 2013; 51: 820-7.
19. Skinner JM, Indrawati L, Cannon J et al. Pre-clinical evaluation of a 15-valent pneumococcal conjugate vaccine (PCV15-CRM197) in an infant-rhesus monkey immunogenicity model. Vaccine 2011; 29: 8870-6.
20. Brueggemann AB, Pai R, Crook DWet al. Vaccine escape recombinants emerge after pneumococcal vaccination in the United States. PLoS Pathog 2007; 3: e168.